Immunotherapy in small bowel adenocarcinoma: a potential role?

Immunol Med

Department of Medical Oncology Ospedale San Raffaele, Vita-Salute University San Raffaele, Comprehensive Cancer Center, Milan, Italy.

Published: March 2024

Small bowel adenocarcinoma (SBA) is a rare tumor with an unfavorable prognosis, and due to its rarity, few studies on its treatment are available. Chemotherapy remains the standard of treatment in advanced disease. Recently immunotherapy has demonstrated to be a valid therapeutic option for many solid tumors. We reviewed the data published in literature to understand the impact of immunotherapy in this cancer.

Download full-text PDF

Source
http://dx.doi.org/10.1080/25785826.2023.2220938DOI Listing

Publication Analysis

Top Keywords

small bowel
8
bowel adenocarcinoma
8
immunotherapy small
4
adenocarcinoma potential
4
potential role?
4
role? small
4
adenocarcinoma sba
4
sba rare
4
rare tumor
4
tumor unfavorable
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!